Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 34,960 shares at $35.19 ($1.2M) on 2022-08-05, disclosed to the SEC on 2022-08-08.
Open-market sale of $1.2M RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 400 | $14K | 1.1% |
| 2 | $35.19 | 17,280 | $608K | 49.4% |
| 3 | $35.19 | 17,280 | $608K | 49.4% |
| Total | $35.19 avg | 34,960 | $1.2M | 100% |
| Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |
| RGNX | SELL | 2021-01-14 | $1.3M | — | Filing → |